NAFDAC Alerts Nigerians to Fake Malaria Drug: Combiart Tablets Under Surveillance 

The National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a critical warning about counterfeit Combiart Dispersible Tablets (20/120mg) circulating in Nigeria. These fake drugs pose a serious threat to public health, with reports emerging from the Federal Capital Territory (FCT) and Rivers State. 

What NAFDAC Discovered 

During routine surveillance by NAFDAC’s Post-Marketing Surveillance Directorate, counterfeit Combiart Tablets were found to contain zero active pharmaceutical ingredients (APIs). This means they are completely ineffective in treating malaria. The agency also noted discrepancies in the product’s labeling: 

    Two different manufacturing dates: June 2023 and February 2023. 

    Two mismatched expiry dates: May 2026 and June 2026. 

    A fake NAFDAC registration number: A11-0299. 

    An expired product license. 

Manufacturer’s Details 

The fake drug falsely claims to be manufactured by Strides Arcolab Limited, located at 36/7, Suragajakkanahalli, Indlavadi Cross, Anekal Taluk, Bangalore, India. 

Why This is Dangerous 

Counterfeit medicines like these are hazardous because they: 

    Do not meet safety or quality standards, making them unreliable for treating illnesses. 

    Can lead to untreated malaria, severe complications, or even death. 

    Create mistrust in the healthcare system. 

Malaria, caused by mosquito bites, is commonly treated with drugs containing Artemether and Lumefantrine, such as Combiart. However, these fake tablets cannot effectively combat the infection. 

NAFDAC’s Actions and Advice 

To address the issue, NAFDAC has: 

    Directed zonal directors and state coordinators nationwide to remove the fake product from the market. 

    Advised importers, distributors, and retailers to verify the authenticity of medical products before handling them. 

Consumers are urged to: 

    Only buy medicines from licensed suppliers. 

    Check product labels for accurate information. 

    Report suspicious drugs to NAFDAC through these channels: 

        Call: 0800-162-3322 

        Email: sf.alert@nafdac.gov.ng 

        Use the Med-Safety app (available on Android and iOS). 

Your health is your wealth—always verify your medicines to protect yourself and your loved ones. Together, we can fight the dangers of counterfeit drugs.

Protecting Public Health 

Healthcare professionals and consumers should report any side effects or adverse reactions linked to counterfeit drugs. These reports can be submitted via NAFDAC’s website, email, or local offices. 

Global Monitoring 

NAFDAC has shared this alert with the World Health Organization (WHO) for global awareness and monitoring. Nigerians must stay vigilant to protect themselves and their loved ones from these life-threatening counterfeit drugs. 

In conclusion, counterfeit drugs pose a significant risk to public health, and the recent circulation of fake Combiart Dispersible Tablets highlights the need for vigilance. Nigerians must prioritize purchasing medicines from licensed suppliers and report any suspicious products to NAFDAC. By working together and staying informed, we can protect ourselves and ensure the safety of our healthcare system. Always remember, your health is in your hands.